Last reviewed · How we verify

NCT05959538: BRIDGE

Building Regulation in Dual Generations 2022-2025

Completed NA Last updated 6 April 2025
What this trial tests

NA trial testing Building Regulation in Dual Generations (BRIDGE) in Maternal Depression in 197 participants. Completed in 16 December 2024.

Timeline
28 October 2022
Primary endpoint
26 June 2024
16 December 2024

Quick facts

Lead sponsorUniversity of Manitoba
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment197
Start date28 October 2022
Primary completion26 June 2024
Estimated completion16 December 2024
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Manitoba

Who can join

18 and older, any sex, with Maternal Depression or Self-Regulation, Emotion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized control trial aims to investigate whether a novel intervention, the "Building Regulation in Dual Generations (BRIDGE)" program, improves mental wellness and parenting practices among mothers of 3 to 5-year-old children who have elevated symptoms of depression. The main two questions this study aims to answer are: * Does participation in the BRIDGE program reduce maternal depression symptoms? * Does participation in the BRIDGE program improve children's mental health? Researchers will compare the BRIDGE intervention to an established mental health intervention (i.e., Dialectical Behaviour Therapy skills group) and to a services-as-usual control group to see if participation in BRIDGE leads to greater improvements than either the general mental health treatment or community services as usual. Participants will: * Complete a set of questionnaires pre- and post-intervention, and at 6-month follow-up. * Complete a virtual assessment with their child at pre- and post-intervention. * Be randomized to BRIDGE, Dialectical Behavioural Therapy(DBT) skills group, or a services-as-usual control group. * Participate in the 16-week BRIDGE or DBT Skills only group, if randomized to either of these groups. If they are randomized to services-as-usual they will receive a list of community resources they can access. * Complete weekly symptom monitoring via questionnaires, if randomized to BRIDGE or DBT Skills * Wear a Fitbit device during pre- and post-intervention, as well as throughout the 16-week intervention period.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Protocol for a randomized control trial of the Building Regulation in Dual Generations Program (BRIDGE): preventing the intergenerational transmission of mental illness in at-risk preschool children.
    Penner-Goeke L, Belows M, Kristjanson A, Andrade BF, et al · · 2023 · PMID 37726821 · DOI 10.1186/s13063-023-07591-8
  2. Protocol for a randomized control trial of the Building Regulation in Dual Generations Program (BRIDGE); Preventing the intergenerational transmission of mental illness in at-risk preschool children
    Penner-Goeke L, Belows M, Kristjanson A, Andrade BF, et al · · 2023 · DOI 10.21203/rs.3.rs-3200761/v1

Verify or expand the search:

Other recruiting trials for Maternal Depression

Currently open trials in the same condition.

Other University of Manitoba trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05959538.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing